share_log

New China Life Insurance's (SHSE:601336) Earnings Have Declined Over Five Years, Contributing to Shareholders 33% Loss

New China Life Insurance's (SHSE:601336) Earnings Have Declined Over Five Years, Contributing to Shareholders 33% Loss

新華保險(SHSE:601336)過去五年的盈利情況受到影響,導致股東損失33%。
Simply Wall St ·  20:55

While not a mind-blowing move, it is good to see that the New China Life Insurance Company Ltd. (SHSE:601336) share price has gained 11% in the last three months. But over the last half decade, the stock has not performed well. In fact, the share price is down 43%, which falls well short of the return you could get by buying an index fund.

儘管這不是一個令人難以置信的舉動,但很高興看到新華人壽保險股份有限公司(SHSE: 601336)的股價在過去三個月中上漲了11%。但是在過去的五年中,該股表現不佳。實際上,股價下跌了43%,遠低於購買指數基金所能獲得的回報。

On a more encouraging note the company has added CN¥3.4b to its market cap in just the last 7 days, so let's see if we can determine what's driven the five-year loss for shareholders.

更令人鼓舞的是,該公司的市值在過去的7天內就增加了34元人民幣,所以讓我們看看我們能否確定是什麼推動了股東五年的虧損。

There is no denying that markets are sometimes efficient, but prices do not always reflect underlying business performance. One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

不可否認,市場有時是有效的,但價格並不總是能反映潛在的業務表現。評估公司情緒變化的一種有缺陷但合理的方法是將每股收益(EPS)與股價進行比較。

During the five years over which the share price declined, New China Life Insurance's earnings per share (EPS) dropped by 4.9% each year. This reduction in EPS is less than the 11% annual reduction in the share price. So it seems the market was too confident about the business, in the past.

在股價下跌的五年中,新華人壽的每股收益(EPS)每年下降4.9%。每股收益的下降幅度低於股價每年下降11%的幅度。因此,過去市場似乎對該業務過於自信。

The graphic below depicts how EPS has changed over time (unveil the exact values by clicking on the image).

下圖描述了 EPS 隨着時間的推移是如何變化的(點擊圖片可以看到確切的值)。

big
SHSE:601336 Earnings Per Share Growth July 14th 2024
SHSE: 601336 每股收益增長 2024 年 7 月 14 日

Before buying or selling a stock, we always recommend a close examination of historic growth trends, available here.

在買入或賣出股票之前,我們始終建議仔細研究歷史增長趨勢,可在此處查閱。

What About Dividends?

分紅呢?

When looking at investment returns, it is important to consider the difference between total shareholder return (TSR) and share price return. Whereas the share price return only reflects the change in the share price, the TSR includes the value of dividends (assuming they were reinvested) and the benefit of any discounted capital raising or spin-off. So for companies that pay a generous dividend, the TSR is often a lot higher than the share price return. We note that for New China Life Insurance the TSR over the last 5 years was -33%, which is better than the share price return mentioned above. This is largely a result of its dividend payments!

在考慮投資回報時,重要的是要考慮股東總回報(TSR)和股價回報之間的差異。儘管股價回報率僅反映股價的變化,但股東總回報率包括股息的價值(假設已進行再投資)以及任何折扣融資或分拆的收益。因此,對於支付豐厚股息的公司來說,股東總回報率通常遠高於股價回報率。我們注意到,對於新華人壽來說,過去5年的股東總回報率爲-33%,好於上述股價回報率。這在很大程度上是其股息支付的結果!

A Different Perspective

不同的視角

While the broader market lost about 17% in the twelve months, New China Life Insurance shareholders did even worse, losing 21% (even including dividends). Having said that, it's inevitable that some stocks will be oversold in a falling market. The key is to keep your eyes on the fundamental developments. Regrettably, last year's performance caps off a bad run, with the shareholders facing a total loss of 6% per year over five years. Generally speaking long term share price weakness can be a bad sign, though contrarian investors might want to research the stock in hope of a turnaround. While it is well worth considering the different impacts that market conditions can have on the share price, there are other factors that are even more important. Consider risks, for instance. Every company has them, and we've spotted 2 warning signs for New China Life Insurance you should know about.

儘管整個市場在十二個月中下跌了約17%,但新中國人壽保險股東的表現甚至更糟,損失了21%(甚至包括股息)。話雖如此,在下跌的市場中,一些股票不可避免地會被超賣。關鍵是要密切關注基本發展。遺憾的是,去年的業績結束了糟糕的表現,股東在五年內每年面臨6%的總虧損。總的來說,長期股價疲軟可能是一個壞兆頭,儘管逆勢投資者可能希望研究該股以期出現轉機。儘管市場狀況可能對股價產生的不同影響值得考慮,但還有其他因素更爲重要。例如,考慮風險。每家公司都有它們,我們發現了兩個你應該知道的新中國人壽保險的警告信號。

For those who like to find winning investments this free list of undervalued companies with recent insider purchasing, could be just the ticket.

對於那些喜歡尋找獲利投資的人來說,這份最近進行內幕收購的被低估公司的免費清單可能只是入場券。

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on Chinese exchanges.

請注意,本文引用的市場回報反映了目前在中國交易所交易的股票的市場加權平均回報。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

對這篇文章有反饋嗎?對內容感到擔憂嗎?請直接聯繫我們。或者,也可以發送電子郵件至編輯團隊 (at) simplywallst.com。
Simply Wall St的這篇文章本質上是籠統的。我們僅使用公正的方法根據歷史數據和分析師的預測提供評論,我們的文章無意作爲財務建議。它不構成買入或賣出任何股票的建議,也沒有考慮到您的目標或財務狀況。我們的目標是爲您提供由基本數據驅動的長期重點分析。請注意,我們的分析可能不考慮最新的價格敏感型公司公告或定性材料。簡而言之,華爾街沒有持有任何上述股票的頭寸。

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

對這篇文章有反饋嗎?擔心內容嗎?直接聯繫我們。或者,發送電子郵件至 editorial-team@simplywallst.com

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論